Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
Recruiting · NCT05295407 · Observational (researchers observe without assigning treatment) · Lead sponsor: Endeavor Health
View the official record on ClinicalTrials.gov →Interventions studied
Genetic Assessment
What this trial is about
Condition: Prostate cancer Intervention: Biopsy and inherited risk assessment
Who can take part
Age range
40 Years to 69 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Consecutive patients undergoing prostate biopsy for detection of prostate cancer
- Aged 40 to 69 years
- Four ethnicity groups (Caucasian, African Americans, East Asians, Latinos)
- PSA between 2.5-10 ng/mL
Exclusion criteria
- Previous diagnosis of prostate cancer.
- Ethnicity outside the inclusion criterion (including mixed ethnicity).
- Any prior PSA test result outside the range of inclusion criterion.
Where it is running
1 location listed across 1 US state.
- NorthShore University HealthSystem - Evanston, Illinois, United States